All companies
/MOLECULAR

FinalDose (opens their website)

Programmable DNA-targeting drugs for cancer.

FinalDose is building a programmable, DNA-targeted therapeutic platform to eliminate cancer at its genetic root. Its approach uses one chassis that can be retargeted in days across the long tail of driver mutations: DNA gives the address, programmability gives the scale and elimination gives the cure.

Founders